SLP
Simulations Plus IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$295.81M
P/E Ratio
—
EPS
$-3.12
Beta
1.19
52W High
$36.45
52W Low
$11.09
50-Day MA
$12.48
200-Day MA
$15.50
Dividend Yield
—
Profit Margin
-78.00%
Forward P/E
21.64
PEG Ratio
9.88
About Simulations Plus Inc
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling, simulation, and prediction of molecule properties using artificial intelligence and machine learning technology worldwide. The company is headquartered in Lancaster, California.
Fundamentals
| Revenue (TTM) | $80.53M |
| Gross Profit (TTM) | $49.91M |
| EBITDA | $13.96M |
| Operating Margin | 23.20% |
| Return on Equity | -38.80% |
| Return on Assets | 3.81% |
| Revenue/Share (TTM) | $4.00 |
| Book Value | $6.31 |
| Price-to-Book | 2.21 |
| Price-to-Sales (TTM) | 3.67 |
| EV/Revenue | 3.155 |
| EV/EBITDA | 15.34 |
| Quarterly Earnings Growth (YoY) | 46.70% |
| Quarterly Revenue Growth (YoY) | 8.30% |
| Shares Outstanding | $20.21M |
| Float | $16.70M |
| % Insiders | 17.27% |
| % Institutions | 85.53% |
Historical Volatility
HV 10-Day
45.32%
HV 20-Day
43.65%
HV 30-Day
40.49%
HV 60-Day
49.18%
HV Rank
12.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($23.67 target)
3
Buy4
HoldData last updated: 4/16/2026